English Corner
In this section you will find useful internet addresses of other support groups for pulmonary fibrosis in various countries and links to relevant scientific publications.
International organisations
Pulmonary Fibrosis News
An American site concerned about various aspects from the patient’s view of pulmonary fibrosis.
Country organisations
Europe
| England | https://pulmonaryfibrosistrust.org |
| GB – England, Wales, Scotland | https://www.actionpf.org |
| Northern Ireland | https://pulmonaryfibrosisni.co.uk |
| Austria | https://www.lungenfibroseforum.at |
| Belgium | https://www.longfibrose.org |
| Eire | https://ilfa.ie |
| France | https://asso-fpf.com |
| Greece | https://ipfgreece.gr |
| Hungary | https://tudofibrozis.hu |
| Italy | https://www.fimarp.it |
| Netherlands | https://longfibrose.nl |
| Norway | https://www.lhl.no |
| Poland | https://ipf.org.pl |
| Portugal | https://www.respira.pt |
| Romania | https://www.apfpi.ro |
| Spain | https://fibrosispulmonar.es |
| Turkey | https://www.pahssc.org.tr |
Rest of the World
Fibroblasts as regulators of lung immunity, repair and fibrosis
Abstract of an article dealing with the mechanisms by which fibroblasts work when causing pulmonary fibrosis
Artificial intelligence has a role in medicine, and in my PF care
An article by a patient using AI in personal medicine
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
Concerning the approval of Boehringer-Ingelheim’s new drug (Nerandomilast – Jascayd in US) for pulmonary fibrosis.
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
The US Federal drug agency approves Jascayd (Fibroneer) in the US.
Research results of Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis Discovered and Designed with a Pioneering AI Approach
A press release about the use of AI in research on pulmonary fibrosis.
